Reata Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
RETA Reata Pharmaceuticals Inc
DPW DPW Holdings Inc
IWN iShares Russell 2000 Value ETF
XNXCX Nuveen California Select Tax-Free Income Portfolio
AMGN Amgen Inc
AMSC American Superconductor Corp
CVBF CVB Financial Corp
PHG Koninklijke Philips NV
IVR Invesco Mortgage Capital Inc
CORE Core-Mark Holding Company Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical needs of patients with a range of serious or life-threatening diseases. The Company's lead product candidates include bardoxolone methyl, which is being studied in Phase III trial for the treatment of pulmonary arterial hypertension (PAH), associated with connective tissue disease (CTD-PAH), as well as a Phase II trial for the treatment of pulmonary hypertension due to interstitial lung disease (PH-ILD), and PAH, each of which are subsets of pulmonary hypertension (PH), Omaveloxolone, which is in Phase II clinical development for the treatment of multiple diseases, including Friedreich's ataxia, mitochondrial myopathies and metastatic melanoma.

Closing Price
$111.93
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
270,032
0
  • Prev Close
    111.93
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    270.0K
  • Last (time)
    3:59p ET 01/15/21
  • Last (size)
    3
  • 52-Wk Range
    88.17 - 257.97
    LowHigh
  • (02/05/20 - 09/28/20)
    26.95%
  • 87.4%
  • Market Cap
    4.0B
  • Shares Outstanding
    36.1M
  • -11.35
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.6
  • 70.04
  • (% of float 12/31/20)
    10.55

Latest News

December 14, 2020
4:54 pm ET
Globe Newswire
4:53 pm ET
Globe Newswire
10:37 am ET
Newsfile
10:09 am ET
Newsfile
8:00 am ET
Globe Newswire
December 12, 2020
5:51 pm ET
PR Newswire
December 11, 2020
9:00 pm ET
Globe Newswire
12:31 pm ET
Globe Newswire
10:26 am ET
Newsfile
December 10, 2020
4:07 pm ET
Newsfile
10:24 am ET
Newsfile
December 09, 2020
4:27 pm ET
Globe Newswire
2:57 pm ET
BusinessWire
1:30 pm ET
Newsfile
11:00 am ET
Globe Newswire
10:12 am ET
Newsfile
December 08, 2020
4:00 pm ET
BusinessWire
12:00 pm ET
Globe Newswire
10:13 am ET
Newsfile
December 07, 2020
6:23 pm ET
Newsfile
10:10 am ET
Newsfile
December 04, 2020
6:00 pm ET
Globe Newswire
12:54 pm ET
Globe Newswire
December 03, 2020
1:24 pm ET
Globe Newswire
December 02, 2020
5:00 pm ET
Globe Newswire
December 01, 2020
11:02 pm ET
PR Newswire
9:48 pm ET
Globe Newswire
4:07 pm ET
Globe Newswire
12:20 pm ET
Globe Newswire
11:17 am ET
PR Newswire
November 29, 2020
11:02 am ET
Newsfile
November 27, 2020
5:00 pm ET
Globe Newswire
November 26, 2020
11:21 am ET
Globe Newswire
November 25, 2020
10:28 pm ET
Globe Newswire
7:04 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.